imported>Brinkery |
imported>Brinkery |
| Line 37: |
Line 37: |
| 1% oder 3% | | 1% oder 3% |
| |5 - 7 d | | |5 - 7 d |
| | | - |
| | | - |
| |} | | |} |
|
| |
|
| Line 46: |
Line 48: |
|
| |
|
|
| |
|
| ===Otitis media chronica epitympanalis=== | | ===== Otitis media chronica epitympanalis ===== |
| <span style="font-size:12.0pt;line-height:107%;font-family: | | <span style="font-size:12.0pt;line-height:107%;font-family: |
| "Arial",sans-serif">Bei der Otitis media chronica epitympanalis besteht die Indikation zur chirurgischen Versorgung, da es zu Komplikationen wir Hörverlust kommen kann.</span> | | "Arial",sans-serif">Bei der Otitis media chronica epitympanalis besteht die Indikation zur chirurgischen Versorgung, da es zu Komplikationen wie Hörverlust kommen kann.</span> |
| | | |
| {| class="wikitable sortable mw-collapsible filterable MsoTableGrid" border="1" cellspacing="0" cellpadding="0" width="605" style="margin-left:-.25pt;border-collapse:collapse;mso-table-layout-alt:fixed;" | | {| class="wikitable |
| |+ | | |+ |
| | style="width:70.9pt;" width="95" valign="top" |'''<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:Arial">Klinische Situation</span>'''
| | !Klinische Situation |
| | style="width:63.8pt;" width="85" valign="top" |'''<span style="color: black">Präferenz</span>'''
| | !Präferenz |
| | style="width:77.95pt;" width="104" valign="top" |'''<span style="color: black">Substanz</span>'''
| | !Substanz |
| | style="width:3.0cm;" width="113" valign="top" |'''<span style="color: black">Dosierung</span>'''
| | !Dosierung |
| | style="width:49.6pt;" width="66" valign="top" |'''<span style="color: black">Dauer</span>'''
| | !Dauer |
| | style="width:2.0cm;" width="76" valign="top" |'''<span style="color: black">Anpassungen</span>'''
| | !Anpassungen |
| | style="width:49.6pt;" width="66" valign="top" |'''<span style="color: black">Kommentar</span>'''
| | !Kommentar |
| |- style="height:27.7ptpx;" | | |- |
| | rowspan="2" style="width:70.9pt;" width="95" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family: | | | rowspan="2" | |
| Arial">Otitis</span> media <span style="font-family:"Arial",sans-serif;mso-fareast-font-family:Arial">chronica</span><span style="font-family:"Arial",sans-serif;mso-fareast-font-family:Arial;
| | Otitis media chronica |
| mso-ansi-language:NO-BOK"> </span> | | epi- und mesotympanalis |
| | |Therapie der Wahl |
| | |Lokaltherapie mit Ciprofloxacin Ohrtropfen |
| | |2 x 3-4 Gtt. |
| | |5 - 7 d |
| | | - |
| | |Gefahr von Pilzinfektionen bei längerer Anwendung |
| | |- |
| | |zusätzlich |
| | |Antiseptikum |
| | |Natriumhypo-chlorid Spüllösung |
| | 1% oder 3% |
| | |5 - 7 d |
| | | - |
| | | - |
| | |} |
|
| |
|
| <span style="font-family:"Arial",sans-serif;mso-fareast-font-family:Arial">epi- und mesotympanalis</span>
| |
| | style="width:63.8pt;" width="85" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:
| |
| Arial">Therapie der Wahl</span>
| |
| | style="width:77.95pt;" width="104" valign="top" |<span style="font-size:11.0pt">Lokaltherapie mit Ciprofloxacin Ohrtropfen</span>
| |
| | style="width:3.0cm;" width="113" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:
| |
| Arial">2 x 3-4 Gtt.</span>
| |
| | style="width:49.6pt;" width="66" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:
| |
| Arial">5-7d</span>
| |
| | style="width:2.0cm;" width="76" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:
| |
| Arial">-</span>
| |
| | style="width:49.6pt;" width="66" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:Arial">Gefahr von Pilzinfektionen bei längerer Anwendung</span>
| |
| |- style="height:4.9ptpx;"
| |
| | style="width:63.8pt;" width="85" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:
| |
| Arial">zusätzlich</span>
| |
| | style="width:77.95pt;" width="104" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:
| |
| Arial">Antiseptikum</span>
| |
| | style="width:3.0cm;" width="113" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:
| |
| Arial">Natriumhypo-chlorid Spüllösung</span>
| |
|
| |
|
| <span style="font-family:"Arial",sans-serif;mso-fareast-font-family:Arial">1% oder 3%</span>
| |
| | style="width:49.6pt;" width="66" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:
| |
| Arial">5-7d</span>
| |
| | style="width:2.0cm;" width="76" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:
| |
| Arial">-</span>
| |
| | style="width:49.6pt;" width="66" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:Arial">-</span>
| |
| |}
| |
| <span style="font-size:12.0pt;line-height:107%;font-family: | | <span style="font-size:12.0pt;line-height:107%;font-family: |
| "Arial",sans-serif">Im Falle eine Exazerbation ist eine antibiotische Therapie indiziert.</span> | | "Arial",sans-serif">Im Falle eine Exazerbation ist eine antibiotische Therapie indiziert.</span> |
| | | |
| {| class="wikitable sortable mw-collapsible filterable MsoTableGrid" border="1" cellspacing="0" cellpadding="0" width="605" style="margin-left:-.25pt;border-collapse:collapse;mso-table-layout-alt:fixed;" | | {| class="wikitable |
| |+ | | |+ |
| | style="width:70.9pt;" width="95" valign="top" |'''<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:Arial">Klinische Situation</span>''' | | !Klinische Situation |
| | style="width:63.8pt;" width="85" valign="top" |'''<span style="color: black">Präferenz</span>''' | | !Präferenz |
| | style="width:77.95pt;" width="104" valign="top" |'''<span style="color: black">Substanz</span>''' | | !Substanz |
| | style="width:3.0cm;" width="113" valign="top" |'''<span style="color: black">Dosierung</span>''' | | !Dosierung |
| | style="width:49.6pt;" width="66" valign="top" |'''<span style="color: black">Dauer</span>''' | | !Dauer |
| | style="width:2.0cm;" width="76" valign="top" |'''<span style="color: black">Anpassungen</span>''' | | !Anpassungen |
| | style="width:49.6pt;" width="66" valign="top" |'''<span style="color: black">Kommentar</span>''' | | !Kommentar |
| |- style="height:27.7ptpx;" | | |- |
| | rowspan="2" style="width:70.9pt;" width="95" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family: | | | rowspan="2" | |
| Arial">Otitis media chronica</span>
| | Otitis media chronica |
| | epi- und mesotympanalis |
| | |Therapie der Wahl |
| | |Piperacillin/ |
| | Tazobactam |
| | |3 x 4,5 g i.v. |
| | |5 - 7 d |
| | | - |
| | | - |
| | |- |
| | |Alternativ |
| | |Ciprofloxacin |
| | |2 x 500 mg p.o. |
| | |5 - 7 d |
| | | - |
| | | - |
| | |} |
|
| |
|
| <span style="font-family:"Arial",sans-serif;mso-fareast-font-family:Arial">epi- und</span> mesotympanalis
| | S2K-Leitline „Chronische mesotympanale Otitis media (CMOM), AWMF-Register-Nr. 017/074, Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde. Kopf- und Hals-Chirurgie e.V. |
| | style="width:63.8pt;" width="85" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:
| |
| Arial">Therapie der Wahl</span>
| |
| | style="width:77.95pt;" width="104" valign="top" |<span style="font-size:11.0pt">Piperacillin/</span>
| |
| | |
| <span style="font-size:11.0pt">Sulbactam</span>
| |
| | style="width:3.0cm;" width="113" valign="top" |<span style="font-size:12.0pt;font-family:"Arial",sans-serif;
| |
| mso-fareast-font-family:Arial">3 x 4,5 g q8h i.v.</span>
| |
| | style="width:49.6pt;" width="66" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:
| |
| Arial">5-7 d</span>
| |
| | style="width:2.0cm;" width="76" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:
| |
| Arial">-</span>
| |
| | style="width:49.6pt;" width="66" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:Arial">-</span>
| |
| |- style="height:4.9ptpx;"
| |
| | style="width:63.8pt;" width="85" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:
| |
| Arial">Alternativ</span>
| |
| | style="width:77.95pt;" width="104" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:
| |
| Arial">Ciprofloxacin</span>
| |
| | style="width:3.0cm;" width="113" valign="top" |<span style="font-size:12.0pt;font-family:"Arial",sans-serif;
| |
| mso-fareast-font-family:Arial">2 * 500 mg p.o./i.v.</span>
| |
| | style="width:49.6pt;" width="66" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:
| |
| Arial">5-7d</span>
| |
| | style="width:2.0cm;" width="76" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:
| |
| Arial">-</span>
| |
| | style="width:49.6pt;" width="66" valign="top" |<span style="font-family:"Arial",sans-serif;mso-fareast-font-family:Arial">-</span>
| |
| |}
| |